ArticleJournal of diabetes and metabolic disorders2025
Association of resistin rs1862513, rs10401670 and rs3745367 polymorphisms with resistin level and insulin resistance in an Iranian type 2 diabetic population.
Article in Journal of diabetes and metabolic disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Mechanistic Pathways Linking Type 2 Diabetes Mellitus, Hypertension, and Osteoarthritis to Falls in Older Adults: A Scoping Review.Healthcare (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: The study investigates the association of single nucleotide polymorphisms (SNP) in resistin gene (RETN) with resistin level, insulin resistance, and the risk of type 2 diabetes in an early diagnosed type 2 diabetic population of Iran. Methods: The total of 80 healthy subjects and 80 individuals diagnosed with type 2 diabetes. To ascertain the genotypes of rs1862513 and rs3745367, we performed the polymerase chain reaction with restriction fragment length polymorphism (PCR-RFLP) technique. The genotyping of resistin rs10401670 was conducted a Tetra-arms amplification system. Resistin and insulin levels were also measured by the ELISA method. Statistical analyses were performed by SPSS software. Results: Resistin level was increased significantly in patients with type 2 diabetes; a significant difference was seen in biochemical parameters between diabetic and non-diabetic group except high-density lipoprotein cholesterol (HDL-C), low density lipoprotein (LDL-C), and insulin. We did not find statistically a significant association between type 2 diabetes mellitus [T2DM] and resistin gene at SNP. However, rs3745367 exhibit a significant association with resistin level among individuals with diabetes. The serum resistin level exhibited a positive association level with body mass index, FPG and insulin resistance. Additionally, anegative correlation between resistin levels and age, as well as HDL-C was also revealed (P-value < 0.05). Conclusions: No significant association was observed between the rs1862513, rs10401670, and rs3745367 polymorphisms, with the susceptibility to type 2 diabetes. The serum resistin levels was positively correlated body with mass index, FPG and insulin resistance, but negatively correlated with HDL-C.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.